$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Evolving characteristics of AIDS-related lymphoma

Blood, v.96 no.13, 2000년, pp.4084 - 4090  

Levine, Alexandra M. (From the Division of Hematology, Department of Medicine, and Division of Hematopathology, Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California) ,  Seneviratne, Lasika (and the HIV Epidemiology Program, Los Angeles County Department of Health Services, Los Angeles, California.) ,  Espina, Byron M. (From the Division of Hematology, Department of Medicine, and Division of Hematopathology, Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California) ,  Wohl, Amy Rock (and the HIV Epidemiology Program, Los Angeles County Department of Health Services, Los Angeles, California.) ,  Tulpule, Anil (From the Division of Hematology, Department of Medicine, and Division of Hematopathology, Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California) ,  Nathwani, Bharat N. (and the HIV Epidemiology Program, Los Angeles County Department of Health Services, Los Angeles, California.) ,  Gill, Parkash S. (From the Division of Hematology, Department of Medicine, and Divisi)

Abstract AI-Helper 아이콘AI-Helper

Over time, the epidemiologic and demographic characteristics of AIDS have changed in the United States, while the use of highly active antiretroviral therapy has changed the natural history of the disease. The goal of the study was to ascertain any changes in the epidemiologic, immunologic, patholog...

참고문헌 (49)

  1. MMWR. Centers for Disease Control 31 507 1982 Update on acquired immune deficiency syndrome (AIDS)-United States. 

  2. Ann Intern Med. Centers for Disease Control 103 402 1985 10.7326/0003-4819-103-3-402 Revision of the case definition of acquired immunodeficiency syndrome for national reporting-United States. 

  3. Ann Intern Med. Levine 100 7 1984 10.7326/0003-4819-100-1-7 Development of B-cell lymphoma in homosexual men: clinical and immunologic findings. 

  4. N Engl J Med. Ziegler 31 565 1984 10.1056/NEJM198408303110904 Non-Hodgkin's lymphoma in 90 homosexual men. 

  5. Blood. Levine 80 8 1992 10.1182/blood.V80.1.8.8 Acquired immunodeficiency syndrome-related lymphoma. 

  6. Blood. Kalter 66 655 1985 10.1182/blood.V66.3.655.655 Aggressive non-Hodgkin's lymphoma in immunocompromised homosexual males. 

  7. Ann Intern Med. Knowles 108 744 1988 10.7326/0003-4819-108-5-744 Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). 

  8. JAMA. Kaplan 261 5 719 1989 10.1001/jama.1989.03420050069041 AIDS associated non-Hodgkin's lymphoma in San Francisco. 

  9. MMWR. Centers for Disease Control and Prevention 44 81 1995 Update: AIDS among women-United States, 1994. 

  10. MMWR. Centers for Disease Control and Prevention 44 64 1995 Update: acquired immunodeficiency deficiency syndrome-United States, 1994. 

  11. HIV/AIDS Surveillance Report. 10 1 1998 CDC: US HIV and AIDS cases reported through December 1998. 

  12. N Engl J Med. Gulick 337 734 1997 10.1056/NEJM199709113371102 Indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior anti-retroviral therapy. 

  13. N Engl J Med. Hammer 335 1081 1996 10.1056/NEJM199610103351501 (ACTG 175): a trial comparing nucleoside monotherapy with combination therapy in HIV infected adults with CD4 cell counts from 200-500 per cubic millimeter. 

  14. JAMA. Carpenter 277 1962 1997 10.1001/jama.1997.03540480062040 Antiretroviral therapy for HIV infection in 1997: updated recommendations of the International AIDS Society-USA Panel. 

  15. N Engl J Med. Palella 338 13 853 1998 10.1056/NEJM199803263381301 Declining morbidity and mortality among patients with advanced human deficiency infection: HIV Outpatient Study Investigators. 

  16. Br Med J. Ledergerber 319 23 1999 10.1136/bmj.319.7201.23 Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. 

  17. J Acquir Immune Defic Syndr Hum Retrovirol. Rabkin 17 A39 1998 10.1097/00042560-199804010-00125 Declining incidence of Kaposi's sarcoma in AIDS clinical trial group (ACTG) trials [abstract S4]. 

  18. J Acquir Immune Defic Syndr Hum Retrovirol. Jones 17 A38 1998 10.1097/00042560-199804010-00124 Effects of anti retro viral therapy on recent trends in cancers among HIV-infected persons [abstract S3]. 

  19. J Acquir Immune Defic Syndr Hum Retrovirol. Jacobson 17 A39 1998 10.1097/00042560-199804010-00126 Impact of highly effective anti-retroviral therapy on the incidence of malignancies among HIV-infected individuals [abstract S5]. 

  20. J Acquir Immune Defic Syndr Hum Retrovirol. Buchbinder 17 A39 1998 10.1097/00042560-199804010-00128 Combination anti-retroviral therapy and incidence of AIDS-related malignancies [abstract S7]. 

  21. Cancer Res. Carbone 31 1860 1971 Report of the committee on Hodgkin's disease staging classification. 

  22. Cancer. McKelvey 38 1484 1982 10.1002/1097-0142(197610)38:4<1484::AID-CNCR2820380407>3.0.CO;2-I Hydroxydaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. 

  23. Cancer. Scadden 83 2580 1998 10.1002/(SICI)1097-0142(19981215)83:12<2580::AID-CNCR25>3.0.CO;2-C Immunotoxin combined with chemotherapy for patients with AIDS-related non-Hodgkin's lymphoma. 

  24. J Acquir Immune Defic Syndr Hum Retrovirol. Tulpule 14 A39 1997 Treatment of AIDS-related NHL with combination mitoguazone dihydrochloride and low dose CHOP chemotherapy: results of a phase II study [abstract 93]. 

  25. J Clin Oncol. Skarin 1 91 1983 10.1200/JCO.1983.1.2.91 Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). 

  26. JAMA. Levine 226 84 1991 10.1001/jama.1991.03470010088036 Low dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. 

  27. N Engl J Med. Kaplan 336 1641 1997 10.1056/NEJM199706053362304 Low dose compared with standard dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. 

  28. Cancer. Levine 78 517 1996 10.1002/(SICI)1097-0142(19960801)78:3<517::AID-CNCR20>3.0.CO;2-0 Low dose m-BACOD with zalcitabine in patients with AIDS-related lymphoma. 

  29. J Clin Oncol. Gill 5 9 1322 1987 10.1200/JCO.1987.5.9.1322 AIDS related malignant lymphoma: results of prospective treatment trials. 

  30. Ann Intern Med. Levine 105 32 1986 10.7326/0003-4819-105-1-32 Suramin antiviral therapy in AIDS. 

  31. Advanced HIV Disease (AIDS) Quarterly Surveillance Summary: cases reported as of December 31, 1998. 15, 1999 

  32. N Engl J Med. Corey 335 1142 1996 10.1056/NEJM199610103351509 Therapy for HIV virus infection-what have we learned? (editorial). 

  33. J Am Stat Assoc. Mehta 79 427 1983 A network algorithm for the exact treatment of Fisher's exact test in R × C contingency tables. 

  34. Fundamentals of Biostatistics. Rosner 3rd ed. 1990 

  35. The statistical analysis of failure time data. Kalbfliesch 1980 

  36. J Acquir Immune Def Synd Hum Retrovirol. Ammasari 17 A38 1998 AIDS-related primary CNS lymphoma: changes of epidemiological trends and of diagnostic attitudes in the era of HAART [abstract S3]. 

  37. Br Med J. Peters 302 203 1991 10.1136/bmj.302.6770.203 Changing disease patterns in patients with AIDS in a referral center in the United Kingdom: the changing face of AIDS. 

  38. Int J Cancer. Cote 73 645 1997 10.1002/(SICI)1097-0215(19971127)73:5<645::AID-IJC6>3.0.CO;2-X Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. 

  39. Int J Cancer. Biggar 68 754 1996 10.1002/(SICI)1097-0215(19961211)68:6<754::AID-IJC11>3.0.CO;2-0 Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS. 

  40. Lancet. Beral 337 805 1991 10.1016/0140-6736(91)92513-2 AIDS-associated non-Hodgkin's lymphoma. 

  41. MMWR. Centers for Disease Control 36(suppl 1S) 1S 1987 Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. 

  42. Cancer. Levine 68 2466 1991 10.1002/1097-0142(19911201)68:11<2466::AID-CNCR2820681124>3.0.CO;2-G HIV-related lymphoma: prognostic factors predictive of survival. 

  43. Cancer. NCI Non-Hodgkin's Lymphoma Classification Project Writing Committee 55 91 1985 10.1002/1097-0142(19850101)55:1<91::AID-CNCR2820550115>3.0.CO;2-K Classification of non-Hodgkin's lymphomas: reproducibility of major classification systems. 

  44. J Clin Oncol. Straus 16 3601 1998 10.1200/JCO.1998.16.11.3601 Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Groups protocol 142-low dose versus standard dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. 

  45. Blood. Carbone 91 747 1998 Differential expression of bcl-6, CD138/syndecan-1, and EBV-encoded latent membrane protein-1 identifies distinct histogenetic pathways of AIDSrelated non-Hodgkin's lymphomas. 

  46. N Engl J Med. The Non-Hodgkin's Lymphoma Prognostic Factors Project 329 987 1993 10.1056/NEJM199309303291402 Development of a predictive model for aggressive lymphoma: the International NHL Prognostic Factors Project. 

  47. Treatment of HIV related non-Hodgkin's lymphoma adapted to prognostic factors. Third National AIDS Malignancy Conference Tirelli 1999 

  48. Chemotherapy for HVI associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy (HAART) is not associated with excessive toxicity. Third National AIDS Malignancy Conference Ratner 1999 

  49. Program and abstracts of the XIII International AIDS Conference; Durban, South Africa; Romeu 9-14, 2000 Effect of HAART on response to therapy and survival in patients with AIDS-related non-Hodgkin's lymphoma [abstract TuPeB3162]. 

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로